Elsevier

Leukemia Research

Volume 14, Issue 9, 1990, Pages 815-817, 819-821
Leukemia Research

Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells

https://doi.org/10.1016/0145-2126(90)90076-LGet rights and content

Abstract

The lamins A, B and C which are differentially expressed during ontogenesis and differentiation are karyoskeletal proteins forming a polymeric meshwork at the inner nuclear membrane. Using Northern blot analyses we investigated the steady state levels of the three lamin specific RNA transcripts in neoplastic cells derived from 16 untreated patients with acute lymphoblastic leukemia (ALL) or non-Hodgkin's lymphoma (NHL) and in ALL and NHL established cell lines. Whereas lamin B mRNA was present in all, lamin A and C transcripts were observed in none of the malignant cell samples except one of a common-ALL patient (precursor B-ALL, cytoplasmic μ chain negative). All three lamin mRNAs were detected in normal peripheral blood lymphocytes, however, only after mitogenic stimulation with concanavalin A. Our results provide evidence that expression of lamin A and C is repressed in neoplastic blast cells derived from patients with ALL or NHL and suggest that lamin A and C gene repression is not related to cell proliferation but might be relevant to the differentiated stages of the lymphoid cells in vivo.

References (24)

  • T.H. Höger et al.

    Amino acid sequence and molecular characterization of murine lamin B as deduced from cDNA clones

    Eur. J. Cell. Biol.

    (1988)
  • D.E. Smith et al.

    Identification, developmental regulation and response to heat shock of two antigenically related forms of a major nuclear envelope protein in Drosophila embryos: application of an improved method for affinity purification of antibodies using polypeptides immobilized in nitrocellulose blots

    J. Cell. Biol.

    (1984)
  • Cited by (49)

    • Aberrant nuclear lamina contributes to the malignancy of human gliomas

      2022, Journal of Genetics and Genomics
      Citation Excerpt :

      Lamin-deficient cells in vitro exhibited dysmorphic nuclei, resembling cancer cells, demonstrating their importance in cancer development (Bell and Lammerding, 2016). Lamin downregulation was reported in leukemias (Stadelmann et al., 1990) and breast (Capo-chichi et al., 2011), colon (Belt et al., 2011), and gastric cancers (Wu et al., 2009). For instance, upregulation of lamin expression was found in prostate (Leman and Getzenberg, 2002), skin (Tilli et al., 2003), ovarian (Alaiya et al., 1997), and liver cancers (Sun et al., 2010).

    • Unusual Presentations of LMNA-Associated Lipodystrophy with Complex Phenotypes and Generalized Fat Loss: When the Genetic Diagnosis Uncovers Novel Features

      2020, AACE Clinical Case Reports
      Citation Excerpt :

      Patient 2, on the other hand, represents the first report of lymphoma in lipodystrophy caused by a pathogenic variant of LMNA. Reduced or absent expression of nuclear lamins was reported in human malignancies (15), including leukemia and lymphomas (16). A variant similar to p.K486E, p.K486N, has previously been associated with partial lipodystrophy although no detailed description of the index patient was reported in the original paper (17).

    • Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis

      2015, Pathology Research and Practice
      Citation Excerpt :

      They were treated as an integral whole, i.e., lamin A/C, in most studies. Lamin A/C were often found to show loss of expression in cancer cells, including leukemia and lymphoma, colon cancer, gastric cancer [7–9], and EOC [10], but a few studies suggested the differential expression patterns of the two isoforms [11]. To further highlight their differential expression patterns in EOC, we explored the relationships of lamin A and lamin C expression with some clinicopathological features of the disease.

    • Keep-ING balance: Tumor suppression by epigenetic regulation

      2014, FEBS Letters
      Citation Excerpt :

      Like aging, cancer is associated with global misregulation of gene expression [44–46], suggesting that both aging and cancer are in some aspects, developmental diseases. For example, loss of lamin A due to promoter methylation of the lamin A/C gene has been reported for hematologic malignancies [47,48]. While normal B and T cells express lamin A and ING(1), leukemia and lymphoma cells do not, nor do some normal progenitor cells or early B/T cell intermediaries [46,49].

    • Higher order chromatin organization in cancer

      2013, Seminars in Cancer Biology
      Citation Excerpt :

      Generally speaking, methylation patterns are dysregulated in cancer as are other chromatin modifications [58]. It has been known for some time that Lamin A is not present in some hematological malignancies and it is now understood that the promoter region of the LMNA/C gene is hypermethylated in these diseases [16,59]. More recently, while normal B and T cells express Lamin A, leukemia and lymphoma cells do not nor do some normal progenitor cells or early B/T cell intermediaries [58].

    • Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence

      2011, European Journal of Cancer
      Citation Excerpt :

      Signal transduction pathways influenced by lamins include Wnt- and TGFβ-signalling, which are of particular relevance to colon carcinogenesis.19 Although lamins are commonly expressed by most differentiated somatic cells, LMNA expression may be reduced in transformed cells as has been demonstrated for several tumour (sub)types, including colorectal neoplasms.10,20–25 The aim of the present study was to evaluate the protein expression of LMNA in stage II and III colon cancer tissue samples to investigate its potential as a prognostic biomarker that may aid therapy selection.

    View all citing articles on Scopus
    View full text